Israel Relies Primarily on Pfizer and Moderna, Overlooking Other Jabs - Here's Why

For 2021-2022 the Jewish state has purchased 60 million doses of both inoculations, costing the country nearly $2 billion. But as the coronavirus kept developing, more and more started asking whether Israel should be trying out other products.